Last 47 quarters of trend data · Healthcare · Diagnostics & Lab Testing
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -4.91 | 12.39 | — | — | — | — | — | — | — | — | — | 7.59 | 9.88 | — | 4.09 | 5.74 | 13.09 | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | +32.3% | -24.5% | — | — | — | — | — | — | — | — | |
| P/S Ratio | 2.11 | 2.55 | 1.87 | 1.62 | 2.16 | 1.79 | 2.11 | 1.79 | 1.99 | 1.45 | 2.10 | 2.03 | 1.24 | 1.07 | 0.72 | 0.72 | 0.59 | 0.61 | 1.81 | 2.46 | 3.78 |
| — | +42.7% | -11.2% | -9.8% | +8.4% | +23.1% | +0.3% | -11.5% | +61.4% | +35.2% | +190.9% | +182.6% | +108.7% | +75.6% | -60.1% | -70.9% | -84.3% | -80.7% | -50.1% | -19.7% | -18.0% | |
| P/B Ratio | 0.74 | 0.98 | 0.67 | 0.51 | 0.65 | 0.59 | 0.64 | 0.65 | 0.75 | 0.74 | 1.07 | 1.43 | 1.09 | 0.93 | 1.14 | 0.97 | 0.81 | 0.57 | 1.34 | 1.65 | 2.10 |
| — | +67.6% | +4.8% | -22.4% | -13.5% | -20.8% | -40.3% | -54.2% | -31.3% | -20.4% | -6.0% | +47.4% | +35.0% | +63.3% | -15.4% | -41.1% | -61.6% | -68.3% | -36.3% | -14.9% | -7.9% | |
| P/FCF | — | — | — | — | — | — | — | — | 6.35 | 12.68 | 22.03 | 3.84 | 3.16 | 1.69 | 54.73 | — | 7.88 | — | — | — | — |
| — | — | — | — | — | — | — | — | +100.8% | +649.9% | -59.7% | — | -59.9% | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | 5.21 | — | — | — | — | — | — | — | 7.09 | — | 7.48 | 2.92 | 12.10 | 3.17 | 3.83 | 4.56 | — | — | — | — |
| — | — | — | — | — | — | — | — | — | -41.4% | — | +95.3% | -36.0% | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | 10.12 | — | — | — | — | — | — | — | — | — | 10.92 | 3.50 | — | 3.64 | 4.87 | 7.38 | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | +124.5% | -52.6% | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 41.9% | 43.5% | 37.4% | 41.0% | 43.5% | 42.1% | 41.1% | 36.9% | 42.8% | 47.1% | 44.9% | 47.0% | 49.7% | 30.9% | 42.5% | 40.5% | 39.9% | 34.6% | 35.9% | 42.7% | 39.8% |
| — | +3.2% | -8.9% | +11.2% | +1.6% | -10.5% | -8.4% | -21.5% | -13.9% | +52.5% | +5.7% | +16.0% | +24.5% | -10.9% | +18.3% | -5.2% | +0.3% | -34.9% | -45.1% | -29.7% | -36.9% | |
| Operating Margin | -59.2% | 17.8% | -83.0% | -63.0% | -58.0% | -55.4% | -61.0% | -30.9% | -14.1% | -0.1% | -6.2% | 10.2% | 19.1% | -7.3% | 16.4% | 11.8% | 6.4% | -13.6% | -23.9% | -14.7% | -25.1% |
| — | +132.1% | -36.0% | -103.8% | -310.2% | -88321.4% | -885.8% | -402.9% | -174.0% | +99.1% | -137.8% | -13.2% | +199.6% | +46.3% | +168.5% | +180.1% | +125.4% | -597.3% | -245.8% | -244.2% | -375.0% | |
| Net Margin | -59.8% | 20.4% | -80.1% | -72.1% | -50.6% | -63.0% | -53.6% | -28.8% | -11.3% | -1.1% | -6.6% | 26.5% | 12.5% | -5.6% | 17.6% | 12.8% | 4.8% | -23.2% | -29.5% | -16.3% | -27.8% |
| — | +132.4% | -49.5% | -150.0% | -348.4% | -5468.8% | -709.4% | -209.0% | -190.2% | +79.8% | -137.7% | +106.1% | +160.4% | +75.8% | +159.6% | +178.5% | +117.3% | -878.5% | -557.1% | -652.5% | -1385.6% |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -18.3% | 2.0% | -6.8% | -5.5% | -3.7% | -5.1% | -4.0% | -2.6% | -1.1% | -0.1% | -0.8% | 4.8% | 2.8% | -1.2% | 7.2% | 4.5% | 1.6% | -5.2% | -5.3% | -2.7% | -3.8% |
| — | +139.1% | -72.0% | -112.5% | -248.8% | -3410.4% | -375.4% | -153.8% | -137.9% | +88.1% | -111.7% | +7.4% | +71.3% | +76.8% | +234.1% | +265.4% | +143.1% | -1453.5% | -668.5% | -671.9% | -1501.6% | |
| ROA | -15.6% | 1.7% | -5.7% | -4.7% | -3.2% | -4.4% | -3.4% | -2.3% | -1.0% | -0.1% | -0.8% | 4.3% | 2.4% | -1.1% | 6.0% | 3.6% | 1.3% | -4.3% | -4.4% | -2.3% | -3.3% |
| — | +138.7% | -67.1% | -104.1% | -226.1% | -3213.1% | -353.8% | -153.6% | -139.6% | +87.5% | -112.5% | +18.3% | +88.4% | +75.6% | +235.4% | +259.0% | +139.8% | -1352.4% | -636.8% | -643.0% | -1444.3% | |
| ROIC | -32.8% | 2.4% | -10.5% | -8.1% | -7.4% | -8.0% | -8.6% | -5.5% | -2.5% | -0.0% | -1.5% | 3.3% | 6.0% | -1.7% | 6.3% | 3.8% | 1.9% | -2.7% | -4.2% | -2.6% | -3.8% |
| — | +129.4% | -22.5% | -46.4% | -195.0% | -58486.1% | -488.9% | -268.8% | -141.7% | +99.2% | -123.2% | -13.1% | +214.0% | +35.7% | +250.7% | +245.8% | +149.7% | -660.9% | -237.0% | -227.6% | -361.5% |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.04 | 0.04 | 0.13 | 0.04 | 0.04 | 0.04 | 0.04 | 0.04 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.03 | 0.03 | 0.05 | 0.06 | 0.04 | 0.03 | 0.04 |
| — | +2.6% | +260.4% | +8.8% | +42.5% | +25.2% | +17.6% | +13.5% | -29.7% | -24.2% | -0.6% | -8.9% | -31.8% | -31.5% | -27.6% | +6.7% | +43.9% | +78.7% | +171.9% | +109.8% | +125.6% | |
| Debt / EBITDA | — | 1.53 | — | — | — | — | — | — | — | 5.09 | — | 1.19 | 0.74 | 3.79 | 0.42 | 0.68 | 1.55 | — | — | — | — |
| — | — | — | — | — | — | — | — | — | +34.3% | — | +75.1% | -52.5% | — | — | — | — | — | — | — | — | |
| Current Ratio | 6.58 | 8.88 | 5.46 | 6.58 | 7.03 | 7.12 | 12.34 | 9.95 | 12.60 | 12.17 | 11.97 | 9.77 | 8.71 | 7.36 | 6.23 | 4.71 | 3.90 | 4.08 | 4.83 | 4.40 | 5.34 |
| — | +24.7% | -55.7% | -33.9% | -44.2% | -41.5% | +3.1% | +1.8% | +44.8% | +65.4% | +92.1% | +107.6% | +123.1% | +80.3% | +29.1% | +7.1% | -26.9% | -33.3% | -26.3% | -29.2% | -34.4% | |
| Quick Ratio | 5.80 | 7.68 | 4.77 | 5.80 | 6.20 | 6.33 | 10.94 | 8.93 | 11.20 | 10.84 | 10.49 | 8.57 | 7.26 | 5.78 | 4.83 | 3.32 | 2.80 | 2.99 | 3.72 | 3.62 | 4.35 |
| — | +21.3% | -56.4% | -35.0% | -44.6% | -41.6% | +4.3% | +4.2% | +54.4% | +87.6% | +117.1% | +157.9% | +159.0% | +93.1% | +29.9% | -8.1% | -35.6% | -41.2% | -34.1% | -34.6% | -40.6% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying OSUR stock.
OraSure Technologies, Inc.'s current P/E is -4.9x. The average P/E over the last 1 quarters is 12.4x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
OraSure Technologies, Inc.'s current operating margin is -59.2%. Margins have been expanding over recent quarters. Quarterly margins are particularly useful for identifying trend inflections that annual data smooths over.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking OraSure Technologies, Inc.'s business trajectory between earnings reports.